News

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the completion of full enrollment in ...
What should you do if your styrofoam-packaged takeout has gone cold, or you're eating the leftovers the next day? Can you ...
Inc. , (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that the first patient has ...
The current Administration has talked a lot about "Making America Healthy Again” in the fight to reduce chronic disease. Now, the FDA has an ...
said on Thursday that the U.S. FDA will be reviewing a supplemental biologics license application ((sBLA)) for its eye disease drug Eylea HD injection, 8 mg, to expand its label and to broaden its ...
A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...
FDA and Novo Nordisk warn about counterfeit Ozempic in the U.S. with fake serial numbers, posing risks due to unknown ...
A few foods we find may include the word “healthy” on the packaging. Did you know that the FDA has actually defined what “healthy” on a food label means? Or that the FDA recently issued a new rule ...
“In addition to the established efficacy of Camzyos, these meaningful updates to the label reinforce the strong safety profile of the therapy. With robust clinical and real-world data and more ...